LCP1 antibody

Catalog No. ABIN3026153

This Mouse Monoclonal antibody specifically detects LCP1 in ELISA, IF and ICC. It exhibits reactivity toward Human Herpesvirus 5 (HHV-5).

Quick Overview for LCP1 antibody (ABIN3026153)

Target: LCP1 (Lymphocyte Cytosolic Protein 1 (LCP1))

Reactivity: Human Herpesvirus 5 (HHV-5)

Host: Mouse

Clonality: Monoclonal

Conjugate: This LCP1 antibody is un-conjugated

Application: ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)

Grade: Carrier-free

Clone: CMV101

Product Details anti-LCP1 Antibody

Purpose: PP65 Antibody / CMV-p65 / Cytomegalovirus (azide and preservative free)

Purification: Protein G affinity chromatography

Immunogen: Recombinant Cytomegalovirus p65 protein was used as the immunogen for this PP65 antibody.

Isotype: IgG1, kappa

Application Details

Application Notes: The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the PP65 antibody to be titered up or down for optimal performance.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Preservative: Azide free

Storage: 4 °C,-20 °C

Storage Comment: Store the PP65 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Target Details for LCP1

Target: LCP1 (Lymphocyte Cytosolic Protein 1 (LCP1))

Alternative Name: PP65

Background: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.